The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Avelumab (MSB0010718C; anti-PD-L1) as a first-line treatment for patients with advanced NSCLC from the JAVELIN Solid Tumor phase 1b trial: Safety, clinical activity, and PD-L1 expression.
 
Claire F. Verschraegen
No Relationships to Disclose
 
Franklin Chen
Speakers' Bureau - Celgene; Onyx
 
David R. Spigel
No Relationships to Disclose
 
Nicholas Iannotti
No Relationships to Disclose
 
Edward Francis McClay
Honoraria - Bristol-Myers Squibb; Genentech
Speakers' Bureau - Bristol-Myers Squibb; Genentech; Merck
 
Charles H. Redfern
Research Funding - Sharp healthcare (Inst)
 
Jaafar Bennouna
Honoraria - Boehringer Ingelheim; Novartis; Pierre Fabre; roche
Consulting or Advisory Role - Boehringer Ingelheim; Novartis; Pierre Fabre; Roche
 
Matthew H. Taylor
Consulting or Advisory Role - Eisai; Onyx; PDX Pharmacy
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Eisai (Inst); Merck KGaA (Inst); Novartis (Inst)
 
Howard Kaufman
Honoraria - Alkermes; Amgen; EMD Serono; Merck; Prometheus; Sanofi Pasteur
Consulting or Advisory Role - Alkermes; Amgen; Merck; Merck Serono; Prometheus
Speakers' Bureau - Merck
Research Funding - Bristol-Myers Squibb/Medarex
Travel, Accommodations, Expenses - Alkermes; EMD Serono; Sanofi
 
Karen Kelly
Honoraria - Bristol-Myers Squibb; Roche
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Lilly; Synta
Research Funding - Abbvie (Inst); Celgene (Inst); EMD Serono (Inst); Genentech (Inst); Gilead Sciences (Inst); Lilly (Inst); Millennium (Inst); Novartis (Inst); Synta (Inst)
Patents, Royalties, Other Intellectual Property - Author Royalties for UpToDate, an evidence based, peer reviewed information resource, available via the web, desktop, and PDA.
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Clovis Oncology; Lilly; Roche; Synta
 
Marcis Bajars
Employment - EMD Serono
 
Anja von Heydebreck
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Jean-Marie Cuillerot
Employment - EMD Serono
 
Guy Heinrich Maria Jerusalem
Honoraria - Celgene; Novartis; Roche
Consulting or Advisory Role - Amgen; Celgene; Novartis; Pfizer; Roche
Research Funding - MSD; Novartis; Roche
Travel, Accommodations, Expenses - GlaxoSmithKline; Novartis; Roche